
Silicon Laboratories Inc
NASDAQ:SLAB

Balance Sheet
Balance Sheet Decomposition
Silicon Laboratories Inc
Current Assets | 602m |
Cash & Short-Term Investments | 382.2m |
Receivables | 54.5m |
Other Current Assets | 165.4m |
Non-Current Assets | 620.6m |
PP&E | 132.1m |
Intangibles | 412.9m |
Other Non-Current Assets | 75.6m |
Balance Sheet
Silicon Laboratories Inc
Jan-2016 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Jan-2021 | Jan-2022 | Dec-2022 | Dec-2023 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
114
|
141
|
269
|
197
|
227
|
203
|
1 075
|
500
|
228
|
282
|
|
Cash Equivalents |
114
|
141
|
269
|
197
|
227
|
203
|
1 075
|
500
|
228
|
282
|
|
Short-Term Investments |
129
|
154
|
495
|
417
|
499
|
522
|
965
|
692
|
212
|
101
|
|
Total Receivables |
74
|
74
|
71
|
73
|
76
|
95
|
98
|
71
|
29
|
54
|
|
Accounts Receivables |
74
|
74
|
71
|
73
|
76
|
95
|
98
|
71
|
29
|
54
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
54
|
60
|
73
|
75
|
73
|
67
|
49
|
100
|
194
|
106
|
|
Other Current Assets |
53
|
62
|
39
|
65
|
69
|
89
|
52
|
98
|
75
|
60
|
|
Total Current Assets |
423
|
491
|
948
|
827
|
944
|
976
|
2 239
|
1 461
|
738
|
602
|
|
PP&E Net |
131
|
130
|
128
|
139
|
136
|
168
|
174
|
177
|
173
|
154
|
|
PP&E Gross |
131
|
130
|
128
|
139
|
136
|
168
|
174
|
177
|
173
|
154
|
|
Accumulated Depreciation |
86
|
98
|
106
|
119
|
129
|
139
|
121
|
139
|
153
|
172
|
|
Intangible Assets |
121
|
104
|
83
|
171
|
134
|
166
|
119
|
85
|
60
|
36
|
|
Goodwill |
273
|
276
|
288
|
397
|
398
|
632
|
376
|
376
|
376
|
376
|
|
Long-Term Investments |
7
|
5
|
0
|
0
|
0
|
0
|
24
|
28
|
0
|
0
|
|
Other Long-Term Assets |
56
|
77
|
88
|
91
|
62
|
52
|
26
|
43
|
97
|
54
|
|
Other Assets |
273
|
276
|
288
|
397
|
398
|
632
|
376
|
376
|
376
|
376
|
|
Total Assets |
1 012
N/A
|
1 082
+7%
|
1 535
+42%
|
1 624
+6%
|
1 675
+3%
|
1 994
+19%
|
2 958
+48%
|
2 169
-27%
|
1 443
-33%
|
1 223
-15%
|
|
Liabilities | |||||||||||
Accounts Payable |
42
|
40
|
39
|
41
|
39
|
55
|
47
|
90
|
57
|
42
|
|
Accrued Liabilities |
27
|
29
|
42
|
49
|
46
|
47
|
42
|
50
|
24
|
24
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
45
|
0
|
|
Current Portion of Long-Term Debt |
10
|
0
|
0
|
0
|
0
|
135
|
451
|
0
|
0
|
0
|
|
Other Current Liabilities |
63
|
71
|
82
|
55
|
53
|
48
|
129
|
46
|
37
|
31
|
|
Total Current Liabilities |
142
|
140
|
162
|
145
|
138
|
285
|
669
|
186
|
164
|
98
|
|
Long-Term Debt |
68
|
73
|
342
|
355
|
368
|
429
|
0
|
530
|
0
|
0
|
|
Deferred Income Tax |
14
|
13
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
27
|
30
|
68
|
57
|
54
|
80
|
77
|
49
|
71
|
45
|
|
Total Liabilities |
250
N/A
|
255
+2%
|
582
+128%
|
557
-4%
|
560
+0%
|
794
+42%
|
746
-6%
|
764
+2%
|
234
-69%
|
143
-39%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
748
|
802
|
851
|
961
|
981
|
994
|
2 215
|
1 416
|
1 193
|
1 002
|
|
Additional Paid In Capital |
14
|
25
|
103
|
108
|
134
|
204
|
0
|
0
|
17
|
78
|
|
Unrealized Security Profit/Loss |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
0
|
0
|
1
|
2
|
1
|
2
|
2
|
11
|
1
|
0
|
|
Total Equity |
761
N/A
|
827
+9%
|
953
+15%
|
1 067
+12%
|
1 115
+4%
|
1 200
+8%
|
2 212
+84%
|
1 405
-36%
|
1 209
-14%
|
1 080
-11%
|
|
Total Liabilities & Equity |
1 012
N/A
|
1 082
+7%
|
1 535
+42%
|
1 624
+6%
|
1 675
+3%
|
1 994
+19%
|
2 958
+48%
|
2 169
-27%
|
1 443
-33%
|
1 223
-15%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
42
|
42
|
43
|
43
|
44
|
44
|
39
|
32
|
32
|
32
|